Doctors Note Logo

Published on: 9/24/2026

Which A1C test should I ask for if my glucose is borderline?

If your fasting glucose is borderline (100 to 125 mg/dL), ask for a standard NGSP-certified, DCCT-aligned HbA1c drawn in a lab rather than a fingerstick point-of-care version, since the lab test is the one recognized for diagnosing prediabetes (5.7% to 6.4%) and diabetes (6.5% or higher). If you have anemia, sickle cell trait or other hemoglobin variants, recent blood loss or transfusion, pregnancy, or kidney disease, an A1C can read falsely high or low, so a fructosamine test, an oral glucose tolerance test, or a repeat fasting glucose may be more accurate for you. Timing, repeat confirmation on a separate day, and the specific assay method used all affect whether your result is trustworthy, and there are several other factors to consider before you rely on a single number. See below to understand more about which test fits your situation and how to interpret borderline results.

Because borderline glucose sits at the point where small changes in habits and follow-up testing matter most, it helps to organize your symptoms and risk factors before your appointment so you can ask for the right test the first time. Take a free, instant, online symptom check to better understand what may be driving your results and what steps to take next.

Last reviewed for medical accuracy: 09/24/2026

answer background

Explanation

Which A1C Test Should I Ask For If My Glucose Is Borderline?

If you’ve had a blood sugar reading that feels “in-between”—for example, a fasting glucose of 112 mg/dL—you might be wondering where you stand and what to do next. This guide explains which A1C (hemoglobin A1C) test to request, how to interpret your results, and what steps you can take to keep your blood sugar in a healthy range.


Is 112 Glucose High?

A single glucose reading of 112 mg/dL can mean different things depending on when you tested:

  • Fasting glucose (no food for at least 8 hours):
    • Normal: 70–99 mg/dL
    • Prediabetes (borderline): 100–125 mg/dL
    • Diabetes: ≥ 126 mg/dL

  • Random (non-fasting) glucose:
    • Normal: up to about 140 mg/dL
    • If you’re under medical care, your doctor may aim for lower targets.

So, a fasting glucose of 112 mg/dL falls into the prediabetes range. That doesn’t mean you have diabetes right now, but it does signal that your blood sugar is edging higher than ideal.


Why Ask for an A1C Test?

A1C measures the percentage of hemoglobin proteins in your red blood cells that have glucose attached. Because red blood cells live about 3 months, the A1C gives an average of your blood sugar over that period.

Key benefits of A1C testing:

  • Tracks long-term trends, not just one day’s reading
  • Can identify prediabetes (average A1C 5.7–6.4%) before diabetes sets in (A1C ≥ 6.5%)
  • Doesn’t require fasting

Which A1C Test to Request

When you speak with your provider or the lab, here’s what to specify:

  1. Hemoglobin A1C (often just called “A1C” or “HbA1c”)
    – The standard test for average blood sugar over 2–3 months.

  2. NGSP-Certified Laboratory
    – Ask that the lab be certified by the National Glycohemoglobin Standardization Program (NGSP).
    – Ensures your results match the Diabetes Control and Complications Trial (DCCT) reference.

  3. Point-of-Care vs. Lab-Drawn
    – Point-of-care (fingerstick) A1C tests give quick results in a doctor’s office.
    – Lab-drawn venous samples are generally more precise.
    – If you want the most accurate number, request a lab-drawn test.

  4. Additional Tests (if needed)
    – Fructosamine: average glucose over 2–3 weeks. Useful if your red blood cell lifespan is abnormal.
    – Oral Glucose Tolerance Test (OGTT): measures how your body handles sugar over 2 hours.


How to Interpret A1C Results

Once you have your lab report, you’ll see a percentage:

  • Below 5.7%
    – Normal average glucose
  • 5.7% – 6.4%
    – Prediabetes (borderline)
  • 6.5% or higher
    – Diabetes likely
  • Target for people with diabetes
    – Often < 7.0%, but your personal goal may differ

Each 1% change in A1C corresponds to about a 28–29 mg/dL shift in average blood sugar. For example, an A1C of 6.0% roughly equals an average glucose of 126 mg/dL.


What to Do If Your A1C Is Borderline

If your A1C comes back in the prediabetes range, you have an opportunity to prevent or delay diabetes:

  • Nutrition

    • Focus on whole foods: vegetables, lean proteins, whole grains
    • Balance meals (carbs + protein + healthy fats)
    • Watch portion sizes
  • Physical Activity

    • Aim for 150 minutes of moderate exercise per week (e.g., brisk walking, cycling)
    • Include strength training 2 days a week
  • Weight Management

    • Even modest weight loss (5–7% of body weight) can improve blood sugar
    • Work with a dietitian or diabetes educator if possible
  • Regular Monitoring

    • Recheck A1C every 3–6 months until stable
    • Consider home glucose monitoring if recommended

When to Seek Further Evaluation

Borderline results can evolve. Discuss with your doctor whether you need:

  • More frequent blood sugar checks
  • An OGTT for a clearer picture of post-meal glucose spikes
  • Consultation with an endocrinologist

You can also try a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance on when to see your provider.


Speak to a Doctor

This information is not a substitute for medical advice. If you experience:

  • Unexplained weight loss
  • Excessive thirst or urination
  • Sudden vision changes
  • Symptoms that feel severe or life threatening

…please speak to a doctor right away or call emergency services. Early action can make a big difference in health outcomes.


By asking for the right A1C test—an NGSP-certified, lab-drawn hemoglobin A1C—you can get a clear view of your longer-term blood sugar control. If your laboratory result shows prediabetes, lifestyle adjustments and regular follow-up can help you avoid progression to diabetes. And remember, any serious or sudden symptoms warrant an immediate conversation with a healthcare professional.

(References)

  • * Harreiter J, Roden M. [Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019)]. Wien Klin Wochenschr. 2019 May;131(Suppl 1):6-15. doi: 10.1007/s00508-019-1450-4. PMID: 30980151.

  • * Bergman M, Abdul-Ghani M, DeFronzo RA, Manco M, Sesti G, Fiorentino TV, Ceriello A, Rhee M, Phillips LS, Chung S, Cravalho C, Jagannathan R, Monnier L, Colette C, Owens D, Bianchi C, Del Prato S, Monteiro MP, Neves JS, Medina JL, Macedo MP, Ribeiro RT, Filipe Raposo J, Dorcely B, Ibrahim N, Buysschaert M. Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract. 2020 Jul;165:108233. doi: 10.1016/j.diabres.2020.108233. Epub 2020 Jun 1. PMID: 32497744; PMCID: PMC7977482.

  • * Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health. 2021 Apr 1;42:59-77. doi: 10.1146/annurev-publhealth-090419-102644. Epub 2021 Dec 23. PMID: 33355476; PMCID: PMC8026645.

  • * Amarikwa L, Mohamed A, Kim SH, Kossler AL, Dosiou C. Teprotumumab-Related Hyperglycemia. J Clin Endocrinol Metab. 2023 Mar 10;108(4):858-864. doi: 10.1210/clinem/dgac627. PMID: 36300333; PMCID: PMC10211488.

  • * Harreiter J, Roden M. [Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023)]. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):7-17. doi: 10.1007/s00508-022-02122-y. Epub 2023 Apr 20. PMID: 37101021; PMCID: PMC10133036.

  • * Zhang H, Guo Y, Hua G, Guo C, Gong S, Li M, Yang Y. Exercise training modalities in prediabetes: a systematic review and network meta-analysis. Front Endocrinol (Lausanne). 2024;15:1308959. doi: 10.3389/fendo.2024.1308959. Epub 2024 Feb 19. PMID: 38440785; PMCID: PMC10911289.

  • * Unnikrishnan R, Shaw JE, Chan JCN, Wild SH, Peters AL, Orrange S, Roden M, Mohan V. Prediabetes. Nat Rev Dis Primers. 2025 Jul 17;11(1):49. doi: 10.1038/s41572-025-00635-0. Epub 2025 Jul 17. PMID: 40676018.

  • * Wagner R, Selvin E, Sehgal R, Prystupa K, Misra S, Fritsche A, Heni M. Beyond Glucose-Rethinking Prediabetes for Precision Prevention. Diabetes Care. 2026 Feb 1;49(2):226-235. doi: 10.2337/dci25-0054. PMID: 40932411; PMCID: PMC12824784.

  • * Mathioudakis N, Lalani B, Abusamaan MS, Alderfer M, Alver D, Dobs A, Kane B, McGready J, Riekert K, Ringham B, Shehadeh A, Vandi F, Wanigatunga AA, Zade D, Maruthur NM, AI-DPP Study Group. An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial. JAMA. 2025 Dec 16;334(23):2079-2089. doi: 10.1001/jama.2025.19563. PMID: 41144242; PMCID: PMC12560030.

  • * Harreiter J, Roden M. [Diabetes mellitus-definition, classification, diagnosis, screening and prevention (Update 2026)]. Wien Klin Wochenschr. 2026 May;138(Suppl 4):76-86. doi: 10.1007/s00508-025-02627-2. Epub 2026 Apr 30. PMID: 42162460; PMCID: PMC13190416.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.